Fred Alger Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Fred Alger Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,000	Closed	-$706K	–	576
2018 Q4	$706K	Buy	+7,000	New	+$726K	﹤0.01%	338
2016 Q2	–	Sell	-2,425	Closed	-$312K	–	574
2016 Q1	$312K	Sell	2,425 -24,422	-91%	-$2.88M	﹤0.01%	436
2015 Q4	$4.01M	Sell	26,847 -368,990	-93%	-$62.5M	0.02%	276
2015 Q3	$65.7M	Sell	395,837 -117,232	-23%	-$25.8M	0.36%	73
2015 Q2	$124M	Buy	513,069 +30,330	+6%	+$8.08M	0.56%	51
2015 Q1	$136M	Buy	482,739 +222,805	+86%	+$48.3M	0.61%	47
2014 Q4	$40.5M	Buy	259,934 +180,162	+226%	+$33.3M	0.2%	107
2014 Q3	$18.9M	Sell	79,772 -18,390	-19%	-$4.69M	0.09%	179
2014 Q2	$23.2M	Buy	98,162 +27,156	+38%	+$7.16M	0.11%	168
2014 Q1	$23.4M	Buy	71,006 +7,542	+12%	+$2.54M	0.12%	181
2013 Q4	$4.33M	Buy	+63,464	New	+$3.67M	0.02%	346

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Fred Alger Management's ICPT Position: Q1 2019 in Review

Fred Alger Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2019, closing a stake of 7,000 shares — an estimated $706K sold.

Fred Alger Management first reported a position in ICPT in Q4 2013 and held it in 11 quarters. The position peaked at $136M in Q1 2015. 202 funds tracked by Wall St. Rank hold ICPT as of Q1 2019.

Fred Alger Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Fred Alger Management sold 7,000 Intercept Pharmaceuticals, Inc. shares in Q1 2019, an estimated $706K.
Fred Alger Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 11 quarters.
Fred Alger Management's Intercept Pharmaceuticals, Inc. position peaked at $136M in Q1 2015.
202 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2019.

Based on Fred Alger Management's 13F filing for Q1 2019, filed 14 May 2019.